Prof Bianca Rocca speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about the interindividual variability in the extent and duration of platelet thromboxane inhibition by low-dose aspirin

She explains that aspirin 'resistance' became a major topic, despite many having doubts that a 'resistance' was possible.

Prof Rocca details that pharmacologists are concerned with 'variability' and how people respond to the drug.

Read more on the highlights from the 2019 International Aspirin Foundation Scientific Conference here.